1
|
Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy.
|
Ophthalmology
|
1999
|
5.34
|
2
|
Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis.
|
N Engl J Med
|
1996
|
2.38
|
3
|
Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII.
|
Cell
|
1998
|
2.34
|
4
|
Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn.
|
N Engl J Med
|
1984
|
2.26
|
5
|
False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus.
|
J Thromb Haemost
|
2009
|
2.14
|
6
|
One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews.
|
Blood
|
1995
|
2.05
|
7
|
Inherited thrombophilia: Part 1.
|
Thromb Haemost
|
1996
|
2.00
|
8
|
Factor XI deficiency in Ashkenazi Jews in Israel.
|
N Engl J Med
|
1991
|
1.56
|
9
|
Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy.
|
Eye (Lond)
|
1999
|
1.54
|
10
|
Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIA and alpha v beta 3 integrins in platelet protein trafficking.
|
Blood
|
1991
|
1.47
|
11
|
Point mutations regarded as missense mutations cause splicing defects in the factor XI gene.
|
J Thromb Haemost
|
2011
|
1.46
|
12
|
Age estimates of two common mutations causing factor XI deficiency: recent genetic drift is not necessary for elevated disease incidence among Ashkenazi Jews.
|
Am J Hum Genet
|
1999
|
1.38
|
13
|
Inherited thrombophilia: Part 2.
|
Thromb Haemost
|
1996
|
1.34
|
14
|
Clinical and laboratory aspects of disseminated intravascular coagulation (DIC): a study of 118 cases.
|
Thromb Haemost
|
1978
|
1.30
|
15
|
Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel.
|
Blood
|
1991
|
1.28
|
16
|
Inherited platelet disorders.
|
Haemophilia
|
2012
|
1.27
|
17
|
A Glanzmann's thrombasthenia cluster among Iraqi Jews in Israel.
|
Thromb Haemost
|
1984
|
1.17
|
18
|
Carrier frequency of the IVS4 + 4 A-->T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population.
|
Blood
|
1995
|
1.15
|
19
|
Dubin-Johnson syndrome in Israel. I. Clinical, laboratory, and genetic aspects of 101 cases.
|
Q J Med
|
1970
|
1.14
|
20
|
Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease.
|
Ann Rheum Dis
|
2004
|
1.13
|
21
|
Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes.
|
Clin Chem
|
1997
|
1.12
|
22
|
The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel.
|
Proc Natl Acad Sci U S A
|
1991
|
1.12
|
23
|
Risk factors associated with postpartum ovarian vein thrombosis.
|
Thromb Haemost
|
1999
|
1.11
|
24
|
Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion.
|
Blood
|
1979
|
1.07
|
25
|
The role of factor XI in thrombin generation induced by low concentrations of tissue factor.
|
Thromb Haemost
|
2001
|
1.06
|
26
|
Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy.
|
Thromb Res
|
1987
|
1.06
|
27
|
Failure to detect variant (CRM+) plasma thromboplastin antecedent (factor XI) molecules in hereditary plasma thromboplastin antecedent deficiency: a study of 125 patients of several ethnic backgrounds.
|
J Lab Clin Med
|
1985
|
1.04
|
28
|
Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.
|
J Clin Invest
|
1979
|
1.04
|
29
|
Abnormal excretion of the isomers of urinary coproporphyrin by patients with Dubin-Johnson syndrome in Israel.
|
Clin Sci
|
1971
|
1.03
|
30
|
The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin.
|
Blood
|
1997
|
1.03
|
31
|
Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment.
|
Arterioscler Thromb Vasc Biol
|
1999
|
1.01
|
32
|
Immunological studies in combined factor V and factor VIII deficiency.
|
Br J Haematol
|
1977
|
1.00
|
33
|
Combined factor V and factor VIII deficiency among non-Ashkenazi Jews.
|
N Engl J Med
|
1982
|
1.00
|
34
|
Responses of platelets to strains of streptococcus sanguis: findings in healthy subjects, Bernard-Soulier, Glanzmann's, and collagen-unresponsive patients.
|
Thromb Haemost
|
1987
|
0.97
|
35
|
Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction.
|
Br Heart J
|
1990
|
0.97
|
36
|
High gene frequency of factor XI (PTA) deficiency in Ashkenazi Jews.
|
Blood
|
1978
|
0.96
|
37
|
Mendelian diseases among Roman Jews: implications for the origins of disease alleles.
|
J Clin Endocrinol Metab
|
1999
|
0.95
|
38
|
Rare bleeding disorders.
|
Haemophilia
|
2006
|
0.95
|
39
|
Clinical and genetic aspects of Glanzmann's thrombasthenia in Israel: report of 22 cases.
|
Thromb Diath Haemorrh
|
1975
|
0.95
|
40
|
Inherited factor XI deficiency confers no protection against acute myocardial infarction.
|
J Thromb Haemost
|
2003
|
0.94
|
41
|
Type I Glanzmann thrombasthenia patients from the Iraqi-Jewish and Arab populations in Israel can be differentiated by platelet glycoprotein IIIa immunoblot analysis.
|
Blood
|
1987
|
0.94
|
42
|
Linkage of combined factors V and VIII deficiency to chromosome 18q by homozygosity mapping.
|
J Clin Invest
|
1997
|
0.94
|
43
|
Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males.
|
Blood
|
1999
|
0.94
|
44
|
ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families.
|
Blood
|
1999
|
0.93
|
45
|
Prenatal diagnosis of Glanzmann's thrombasthenia.
|
Lancet
|
1986
|
0.93
|
46
|
A single genetic origin for a common Caucasian risk factor for venous thrombosis.
|
Blood
|
1997
|
0.93
|
47
|
Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency.
|
J Thromb Haemost
|
2014
|
0.93
|
48
|
Immunologic and biochemical characterization of homozygous and heterozygous Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations of Israel: comparison of techniques for carrier detection.
|
Br J Haematol
|
1986
|
0.92
|
49
|
Dental surgery in patients with severe factor XI deficiency without plasma replacement.
|
Blood Coagul Fibrinolysis
|
1992
|
0.92
|
50
|
Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
|
J Lab Clin Med
|
1986
|
0.92
|
51
|
Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism.
|
Stroke
|
2001
|
0.91
|
52
|
Prenatal diagnosis of Glanzmann thrombasthenia using the polymorphic markers BRCA1 and THRA1 on chromosome 17.
|
Br J Haematol
|
1998
|
0.91
|
53
|
Glanzmann thrombasthenia: new insights from an historical perspective.
|
Semin Hematol
|
1994
|
0.90
|
54
|
A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene.
|
Blood
|
1998
|
0.89
|
55
|
ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Study Group.
|
Semin Thromb Hemost
|
1996
|
0.89
|
56
|
Combined factor-V and factor-VIII deficiency: report of four cases.
|
Br J Haematol
|
1969
|
0.88
|
57
|
Association between hyperflexibility of the thumb and an unexplained bleeding tendency: is it a rule of thumb?
|
Br J Haematol
|
1998
|
0.87
|
58
|
Repeat infusion of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction and early recurrent myocardial ischemia.
|
J Am Coll Cardiol
|
1990
|
0.87
|
59
|
Effects of ADP and ATP on bovine fibrinogen- and ristocetin-induced platelet aggregation in Glanzmann's thrombasthenia.
|
Br J Haematol
|
1975
|
0.87
|
60
|
Patients with Glanzmann thrombasthenia lacking platelet glycoprotein alpha(IIb)beta(3) (GPIIb/IIIa) and alpha(v)beta(3) receptors are not protected from atherosclerosis.
|
Circulation
|
2002
|
0.86
|
61
|
[Massive sublingual hemorrhage due to coumadin causing suffocation].
|
Harefuah
|
1970
|
0.86
|
62
|
A 13-bp deletion in alpha(IIb) gene is a founder mutation that predominates in Palestinian-Arab patients with Glanzmann thrombasthenia.
|
J Thromb Haemost
|
2005
|
0.86
|
63
|
Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction.
|
Am J Cardiol
|
1989
|
0.86
|
64
|
Cyclosporine therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus.
|
Thromb Haemost
|
1996
|
0.86
|
65
|
Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusion.
|
Blood Coagul Fibrinolysis
|
1998
|
0.86
|
66
|
A novel Phe171Cys mutation in integrin alpha causes Glanzmann thrombasthenia by abrogating alphabeta complex formation.
|
J Thromb Haemost
|
2004
|
0.86
|
67
|
Hereditary deficiency of all vitamin K-dependent procoagulants and anticoagulants.
|
Br J Haematol
|
1990
|
0.85
|
68
|
Evidence for the participation of both activated factor XII and activated factor IX in cold-promoted activation of factor VII.
|
Thromb Res
|
1978
|
0.85
|
69
|
Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome.
|
J Biol Chem
|
2001
|
0.85
|
70
|
Could the 185delAG BRCA1 mutation be an ancient Jewish mutation?
|
Eur J Hum Genet
|
1998
|
0.85
|
71
|
Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor.
|
Blood
|
1999
|
0.84
|
72
|
Methionine synthase A2756G and methylenetetrahydrofolate reductase A1298C polymorphisms are not risk factors for idiopathic venous thromboembolism.
|
Hematol J
|
2001
|
0.84
|
73
|
Thrombophilia as a cause for central and branch retinal artery occlusion in patients without an apparent embolic source.
|
Eye (Lond)
|
2001
|
0.84
|
74
|
Disseminated intravascular coagulation in experimental heatstroke.
|
Thromb Diath Haemorrh
|
1971
|
0.84
|
75
|
High prevalence and impact of subnormal serum vitamin B12 levels in Israeli elders admitted to a geriatric hospital.
|
J Nutr Health Aging
|
2001
|
0.84
|
76
|
Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI.
|
J Thromb Haemost
|
2006
|
0.83
|
77
|
Bleeding predictors in factor-XI-deficient patients.
|
Blood Coagul Fibrinolysis
|
1997
|
0.83
|
78
|
Structural integrity of the glycoprotein IIb and IIIa genes in Glanzmann thrombasthenia patients from Israel.
|
Blood
|
1988
|
0.83
|
79
|
Detection of the Glanzmann's thrombasthenia mutations in Arab and Iraqi-Jewish patients by polymerase chain reaction and restriction analysis of blood or urine samples.
|
Thromb Haemost
|
1991
|
0.83
|
80
|
Trp207Gly in platelet glycoprotein Ibalpha is a novel mutation that disrupts the connection between the leucine-rich repeat domain and the disulfide loop structure and causes Bernard-Soulier syndrome.
|
J Thromb Haemost
|
2006
|
0.83
|
81
|
Extensive venous and arterial thrombosis associated with an inhibitor to activated protein C.
|
Blood
|
1999
|
0.83
|
82
|
Ilio-psoas hematoma--its detection, and treatment with special reference to hemophilia.
|
Arch Orthop Trauma Surg
|
1982
|
0.82
|
83
|
von Willebrand factor multimer patterns in pregnancy-induced hypertension.
|
Thromb Haemost
|
1989
|
0.82
|
84
|
A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency.
|
J Thromb Haemost
|
2004
|
0.82
|
85
|
New observations on factor XI deficiency.
|
Haemophilia
|
2004
|
0.81
|
86
|
Factor XIII deficiency due to a Leu660Pro mutation in the factor XIII subunit-a gene in three unrelated Palestinian Arab families.
|
Thromb Haemost
|
1997
|
0.81
|
87
|
Sequestration studies with chromium-51 labeled red cells as criteria for splenectomy.
|
Isr J Med Sci
|
1968
|
0.81
|
88
|
Identification of a region in glycoprotein IIIa involved in subunit association with glycoprotein IIb: further lessons from Iraqi-Jewish Glanzmann thrombasthenia.
|
Blood
|
2001
|
0.81
|
89
|
Dubin-Johnson syndrome in Israel. II. Association with factor-VII deficiency.
|
Q J Med
|
1970
|
0.80
|
90
|
Glanzmann thrombasthenia in two Iraqi-Jewish siblings is caused by a novel splice junction mutation in the glycoprotein IIb.
|
Blood Coagul Fibrinolysis
|
1998
|
0.80
|
91
|
Platelet glycoprotein IIb/IIIa receptors and Glanzmann's thrombasthenia.
|
Arterioscler Thromb Vasc Biol
|
2000
|
0.80
|
92
|
Factor XI deficiency: detection and management during urological surgery.
|
J Urol
|
1978
|
0.80
|
93
|
Fibrinogen synthesis in adrenalectomized rabbits.
|
Proc Soc Exp Biol Med
|
1973
|
0.80
|
94
|
Possible role of fibrinogen in the aggregation of white blood cells.
|
Thromb Haemost
|
1987
|
0.79
|
95
|
Normal response of factor VIII and von Willebrand factor to 1-deamino-8D-arginine vasopressin in nephrogenic diabetes insipidus.
|
J Clin Endocrinol Metab
|
1988
|
0.79
|
96
|
Coupled amidolytic assay for factor VII: its use with a clotting assay to determine the activity state of factor VII.
|
Blood
|
1978
|
0.79
|
97
|
An αIIb mutation in patients with Glanzmann thrombasthenia located in the N-terminus of blade 1 of the β-propeller (Asn2Asp) disrupts a calcium binding site in blade 6.
|
J Thromb Haemost
|
2011
|
0.79
|
98
|
A relatively high frequency of severe (type III) von Willebrand's disease in Israel.
|
Br J Haematol
|
1986
|
0.79
|
99
|
The inheritance of Dubin-Johnson syndrome.
|
Isr J Med Sci
|
1974
|
0.78
|
100
|
[Massive bleeding due to primary fibrinolysis following rhinoplasty].
|
Harefuah
|
1972
|
0.78
|
101
|
Effect of phenobarbital on liver functions in patients with Dubin-Johnson syndrome.
|
Gastroenterology
|
1974
|
0.78
|
102
|
Decreased factor VIII clotting antigen levels in the combined factor V and VIII deficiency.
|
Thromb Res
|
1984
|
0.78
|
103
|
Association of the hemophilia A carrier state and hemorrhagic thrombocytopathy with dilatation of the platelet membrane complex.
|
Acta Haematol
|
1984
|
0.78
|
104
|
Severe factor XI deficiency caused by a Gly555 to Glu mutation (factor XI-Glu555): a cross-reactive material positive variant defective in factor IX activation.
|
J Thromb Haemost
|
2004
|
0.78
|
105
|
Glanzmann thrombasthenia caused by an 11.2-kb deletion in the glycoprotein IIIa (beta3) is a second mutation in Iraqi Jews that stemmed from a distinct founder.
|
Blood
|
1997
|
0.78
|
106
|
Severe hereditary deficiency of factor VII during pregnancy. Evidence for the absence of transplacental diffusion of factor VII.
|
Thromb Diath Haemorrh
|
1970
|
0.77
|
107
|
Glanzmann's thrombasthenia associated with deletion-insertion and alternative splicing in the glycoprotein IIb gene.
|
Blood
|
1995
|
0.77
|
108
|
Extra-adrenal effect of ACTH on fibrinogen synthesis.
|
Am J Physiol
|
1973
|
0.77
|
109
|
Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patients.
|
J Thromb Haemost
|
2006
|
0.77
|
110
|
The human platelet alphaIIb gene is not closely linked to its integrin partner beta3.
|
Blood
|
1999
|
0.77
|
111
|
Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis.
|
Blood
|
1996
|
0.77
|
112
|
Clinical bleeding due to diclofenac (Voltaren)
|
Arthritis Rheum
|
1982
|
0.77
|
113
|
The relative frequency of hereditary thrombotic disorders among 107 patients with thrombophilia in Israel.
|
Thromb Haemost
|
1989
|
0.77
|
114
|
Hepatic computerized tomography in the Dubin-Johnson syndrome: increased liver density as a diagnostic aid.
|
Comput Radiol
|
1986
|
0.77
|
115
|
Mutations in the alphaIIb and beta3 genes that cause Glanzmann thrombasthenia can be distinguished by a simple procedure using transformed B-lymphocytes.
|
Thromb Haemost
|
1998
|
0.77
|
116
|
Dubin-Johnson Syndrome. Abnormal excretion of the isomers of urinary coproporphyrin by clinically unaffected family members.
|
Isr J Med Sci
|
1974
|
0.77
|
117
|
Coexistence of factor XI (plasma thromboplastin antecedent) deficiency and Gaucher's disease.
|
Isr J Med Sci
|
1976
|
0.77
|
118
|
Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews.
|
J Thromb Haemost
|
2013
|
0.77
|
119
|
Three residues at the interface of factor XI (FXI) monomers augment covalent dimerization of FXI.
|
J Thromb Haemost
|
2009
|
0.77
|
120
|
Definition of the population at risk of bleeding due to factor XI deficiency in Ashkenazic Jews and the value of activated partial thromboplastin time in its detection.
|
Isr J Med Sci
|
1981
|
0.77
|
121
|
Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma.
|
Haemophilia
|
2008
|
0.77
|
122
|
Hemophilia and other clotting disorders.
|
Isr J Med Sci
|
1974
|
0.77
|
123
|
The inheritance of type I and type III von Willebrand's disease in Israel: linkage analysis, carrier detection and prenatal diagnosis using three intragenic restriction fragment length polymorphisms.
|
Blood Coagul Fibrinolysis
|
1992
|
0.76
|
124
|
The effect of the plasma levels of proteins C and S on the prediction of warfarin maintenance dose requirements.
|
Clin Pharmacol Ther
|
1992
|
0.76
|
125
|
Association of von Willebrand's disease with plasma cell dyscrasia and gastrointestinal angiodysplasia.
|
Isr J Med Sci
|
1990
|
0.76
|
126
|
Multiple myeloma: early vertebral involvement assessed by computerised tomography.
|
Skeletal Radiol
|
1984
|
0.76
|
127
|
Angio-immunoblastic lymphadenopathy: a case with a 17-year follow-up.
|
Postgrad Med J
|
1982
|
0.75
|
128
|
The Dubin Johnson syndrome and pregnancy.
|
Acta Hepatogastroenterol (Stuttg)
|
1977
|
0.75
|
129
|
[The heterogeneity of hereditary disorders of blood coagulation].
|
Harefuah
|
1974
|
0.75
|
130
|
ADP-coupled integrin regulation by the extracellular redox system.
|
Pathophysiol Haemost Thromb
|
2006
|
0.75
|
131
|
Purpura fulminans induced by disseminated intravascular coagulation following infection in 2 unrelated children with double heterozygosity for factor V Leiden and protein S deficiency.
|
Thromb Haemost
|
1997
|
0.75
|
132
|
Lysine binding to activated human platelets and its similarity to fibrinogen binding.
|
Biochim Biophys Acta
|
1985
|
0.75
|
133
|
Factor VIII gene rearrangement in hemophilia A carrier detection: a word of caution.
|
Blood
|
1994
|
0.75
|
134
|
The prevalence of factor V G1691A but not of prothrombin G20210A and methylenetetrahydrofolate reductase C677T is remarkably low in French Basques.
|
J Thromb Haemost
|
2004
|
0.75
|
135
|
Cold-promoted activation of factor VII: is It a problem under blood bank conditions?
|
Haemostasis
|
1983
|
0.75
|
136
|
[Primary hypercoagulable states].
|
Harefuah
|
1987
|
0.75
|
137
|
Parotid gland hemorrhage as a complication of coumarin compound ingestion.
|
Arch Otorhinolaryngol
|
1985
|
0.75
|
138
|
Seven novel mutations in the factor XIII A-subunit gene causing hereditary factor XIII deficiency in 10 unrelated families.
|
J Thromb Haemost
|
2004
|
0.75
|
139
|
Chronic monocytic leukemia: a case with an eight-year survival.
|
Isr J Med Sci
|
1968
|
0.75
|
140
|
Haemophiliac hands--a three year follow-up study.
|
Hand
|
1982
|
0.75
|
141
|
The effect of leukocytic extract on fibrinogen synthesis in rabbits.
|
Thromb Res
|
1975
|
0.75
|
142
|
Molecular characterization of four novel mutations causing factor VII deficiency.
|
Hematol J
|
2000
|
0.75
|
143
|
Characterization of three mutations causing von Willebrand disease type IIA in five unrelated families.
|
Thromb Haemost
|
1992
|
0.75
|
144
|
Effect of corticosteroids upon fibrinogen metabolism in rabbits.
|
Thromb Diath Haemorrh
|
1973
|
0.75
|
145
|
[Resistance to activated protein C--a novel cause of thrombophilia].
|
Harefuah
|
1995
|
0.75
|
146
|
Hereditary deficiency of blood clotting factor VII and Dubin-Johnson syndrome in an Israeli family.
|
Isr J Med Sci
|
1970
|
0.75
|
147
|
Detection of Haemophilia A carriers by replicate factor VIII activity and factor VIII antigenicity determinations.
|
Br J Haematol
|
1979
|
0.75
|
148
|
Delayed incorporation of (75Se)selenomethionine into fibrinogen: its effect upon kinetic studies of fibrinogen with (75Se)selenomethionine in rabbits.
|
Br J Haematol
|
1974
|
0.75
|
149
|
[Ambulatory oral surgery in hemophiliacs].
|
Harefuah
|
1980
|
0.75
|
150
|
Unusual course of infectious mononucleosis.
|
JAMA
|
1967
|
0.75
|
151
|
[International postgraduate training program in medicine: survey of 13 training courses, 1988-1994].
|
Harefuah
|
1995
|
0.75
|
152
|
Purpura fulminans in an adult.
|
Isr J Med Sci
|
1986
|
0.75
|
153
|
Combined factors V and VIII deficiency--the solution.
|
Haemophilia
|
1998
|
0.75
|
154
|
Hereditary factor XIII deficiency: report of four families and definition of the carrier state.
|
Br J Haematol
|
1984
|
0.75
|
155
|
Prenatal diagnosis of hereditary protein C deficiency.
|
N Engl J Med
|
1985
|
0.75
|
156
|
Acquired von Willebrand disease in a patient with angiodysplasia resulting from immune-mediated clearance of von Willebrand factor.
|
Br J Haematol
|
1997
|
0.75
|
157
|
Effects of prolonged administration of high molecular levan on hematological parameters in rabbits.
|
Biochem Exp Biol
|
1977
|
0.75
|
158
|
Quantitation by flow cytometry of anthracycline drug uptake by peripheral blood and bone marrow cells in human leukemias.
|
Exp Hematol
|
1986
|
0.75
|
159
|
Gilbert syndrome and factor-VII deficiency.
|
Lancet
|
1970
|
0.75
|
160
|
[Late onset of hemorrhagic disease of the newborn].
|
Harefuah
|
1977
|
0.75
|
161
|
A mutation in the β3 cytoplasmic tail causes variant Glanzmann thrombasthenia by abrogating transition of αIIb β3 to an active state.
|
J Thromb Haemost
|
2012
|
0.75
|
162
|
Thrombasthenia in Iraqi Jews.
|
Isr J Med Sci
|
1974
|
0.75
|
163
|
A 14-bp deletion (codon 554 del AAGgtaacagagtg) at exon 14/intron N junction of the coagulation factor XI gene disrupts splicing and causes severe factor XI deficiency.
|
Hum Mutat
|
1996
|
0.75
|
164
|
Hereditary protein C deficiency during pregnancy.
|
Am J Obstet Gynecol
|
1987
|
0.75
|
165
|
Multiple myeloma with terminal erythroleukemia.
|
Acta Haematol
|
1976
|
0.75
|
166
|
Characterization of mutations causing factor VII deficiency in 61 unrelated Israeli patients.
|
J Thromb Haemost
|
2004
|
0.75
|
167
|
A proposed system of classification of hemophilia centers for the World Federation of Hemophilia (W.F.H.).
|
Scand J Haematol Suppl
|
1984
|
0.75
|
168
|
Factor VII in plasma of women taking oral contraceptives. Lack of cold activation under blood bank conditions.
|
Transfusion
|
1984
|
0.75
|
169
|
Ala244Val is a common, probably ancient mutation causing factor VII deficiency in Moroccan and Iranian Jews.
|
Thromb Haemost
|
1996
|
0.75
|
170
|
The activated partial thromboplastin time and factor XI deficiency.
|
Ann Intern Med
|
1986
|
0.75
|
171
|
Abciximab in carotid stenting for postsurgical carotid restenosis: intermediate results.
|
J Endovasc Ther
|
2000
|
0.75
|
172
|
Patterns of incorporation of 75 Se-methionine into fibrinogen and other plasma proteins in rabbits stimulated by different test conditions.
|
Thromb Diath Haemorrh
|
1973
|
0.75
|